Kiora Pharmaceuticals Inc...

2.83
0.02 (0.71%)
At close: Apr 03, 2025, 3:59 PM
2.92
3.08%
After-hours: Apr 03, 2025, 07:24 PM EDT

Kiora Pharmaceuticals Statistics

Share Statistics

Kiora Pharmaceuticals has 3M shares outstanding. The number of shares has increased by 1.02% in one year.

Shares Outstanding 3M
Shares Change (YoY) 1.02%
Shares Change (QoQ) 0%
Owned by Institutions (%) 1.12%
Shares Floating 2.8M
Failed to Deliver (FTD) Shares 433
FTD / Avg. Volume 1.37%

Short Selling Information

The latest short interest is 3.61K, so 0.12% of the outstanding shares have been sold short.

Short Interest 3.61K
Short % of Shares Out 0.12%
Short % of Float 0.13%
Short Ratio (days to cover) 0.27

Valuation Ratios

The PE ratio is 3.56 and the forward PE ratio is -1.54. Kiora Pharmaceuticals's PEG ratio is -0.03.

PE Ratio 3.56
Forward PE -1.54
PS Ratio 0.8
Forward PS 0.4
PB Ratio 0.5
P/FCF Ratio 1.49
PEG Ratio -0.03
Financial Ratio History

Enterprise Valuation

Kiora Pharmaceuticals has an Enterprise Value (EV) of 9.04M.

EV / Sales 0.56
EV / EBITDA 1.59
EV / EBIT 1.06
EV / FCF 1.06

Financial Position

The company has a current ratio of 4.94, with a Debt / Equity ratio of 0.

Current Ratio 4.94
Quick Ratio 4.94
Debt / Equity 0
Debt / EBITDA 0.01
Debt / FCF 0.01
Interest Coverage 210.31

Financial Efficiency

Return on Equity is 13.95% and Return on Invested Capital is 9.39%.

Return on Equity 13.95%
Return on Assets 9.85%
Return on Invested Capital 9.39%
Revenue Per Employee $1.33M
Profits Per Employee $299.56K
Employee Count 12
Asset Turnover 0.44
Inventory Turnover n/a

Taxes

Income Tax 2.07M
Effective Tax Rate 36.49%

Stock Price Statistics

The stock price has increased by -48.03% in the last 52 weeks. The beta is -0.46, so Kiora Pharmaceuticals's price volatility has been lower than the market average.

Beta -0.46
52-Week Price Change -48.03%
50-Day Moving Average 3.41
200-Day Moving Average 3.63
Relative Strength Index (RSI) 33.13
Average Volume (20 Days) 31.53K

Income Statement

In the last 12 months, Kiora Pharmaceuticals had revenue of 16.02M and earned 3.59M in profits. Earnings per share was 1.99.

Revenue 16.02M
Gross Profit 16.02M
Operating Income 4.51M
Net Income 3.59M
EBITDA 5.7M
EBIT 5.68M
Earnings Per Share (EPS) 1.99
Full Income Statement

Balance Sheet

The company has 3.79M in cash and 57.17K in debt, giving a net cash position of 3.74M.

Cash & Cash Equivalents 3.79M
Total Debt 57.17K
Net Cash 3.74M
Retained Earnings -143.38M
Total Assets 36.48M
Working Capital 23.7M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 8.56M and capital expenditures -6.26K, giving a free cash flow of 8.55M.

Operating Cash Flow 8.56M
Capital Expenditures -6.26K
Free Cash Flow 8.55M
FCF Per Share 2.21
Full Cash Flow Statement

Margins

Gross margin is 100%, with operating and profit margins of 28.15% and 22.44%.

Gross Margin 100%
Operating Margin 28.15%
Pretax Margin 35.33%
Profit Margin 22.44%
EBITDA Margin 35.58%
EBIT Margin 28.15%
FCF Margin 53.39%

Dividends & Yields

KPRX does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Payout Ratio n/a
Earnings Yield 28.13%
FCF Yield 66.93%
Dividend Details

Analyst Forecast

The average price target for KPRX is $10, which is 261% higher than the current price. The consensus rating is "Buy".

Price Target $10
Price Target Difference 261%
Analyst Consensus Buy
Analyst Count 1
Stock Forecasts

Stock Splits

The last stock split was on Jun 11, 2024. It was a backward split with a ratio of 1:9.

Last Split Date Jun 11, 2024
Split Type backward
Split Ratio 1:9

Scores

Altman Z-Score -3.25
Piotroski F-Score 7